LIMK1 and schizophrenia: In this study, MAP6 KO mice were used as a model of schizophrenia and the impact of long-term treatment with Pyr1, a LIMK inhibitor and a modulator of MT/actin dynamic (Prudent et al., 2012), on MAP6 KO mice defects, was analyzed in terms of behavioral, anatomic and physiological parameters.